Lupin completes acquisition of VISUfarma
The integration of VISUfarma has expanded Lupin’s ophthalmology portfolio to over 60 branded products spanning dry eye, glaucoma,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ophthalmology
Lupin acquires VISUfarma to strengthen ophthalmology business
Lupin’s wholly owned subsidiary, Nanomi B.V. ('Nanomi'), has signed a definitive agreement for the acquisition of VISUfarma B.V.…
Biocon Biologics obtains USFDA approval for biosimilar Aflibercept
Yesafili enters U.S. market to treat ophthalmology conditions
Allergan’s Media Conclave on World Sight Day spotlights eyecare in workplace
Experts shed light on the prevalence of eye-related issues in today's digital age and dispelled common myths surrounding eye…
Biocon Biologics gets positive CHMP opinion for YESAFILI, biosimilar Aflibercept
YESAFILI is intended for the treatment of neovascular age-related macular degeneration, visual impairment due to macular oedema…
GUERISON forays into India’s ophthalmology market
Launches its new range of 25 allopathy ophthalmic products
Bayer and Zydus extend their JV for three years
The joint venture will continue to operate in therapies including cardiology, diabetes, women’s health, ophthalmology and…